M&A Deal Summary

IQVIA Acquires Expression Analysis

On August 13, 2012, IQVIA acquired life science company Expression Analysis

Acquisition Highlights
  • This is IQVIA’s 6th transaction in the Life Science sector.
  • This is IQVIA’s 9th transaction in the United States.
  • This is IQVIA’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2012-08-13
Target Expression Analysis
Sector Life Science
Buyer(s) IQVIA
Deal Type Add-on Acquisition

Target

Expression Analysis

Durham, North Carolina, United States
Expression Analysis, Inc. is a provider of genomics testing and analysis to biopharma, academic, government and non-profit customers. EA provides whole genome to focused-set gene expression and genotyping assays, along with next-generation sequencing services, sequence enrichment technologies and bioinformatics support.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IQVIA

Durham, North Carolina, United States
Category Company
Sector Life Science
Employees87,000
Revenue 15.0B USD (2023)
DESCRIPTION
Quintiles office in San Diego, California.
Quintiles office in San Diego, California.

IQVIA is a provider of advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. IQVIA was founded in 2016 and is based in Durham, North Carolina.

DEAL STATS #
Overall 10 of 18
Sector (Life Science) 6 of 8
Type (Add-on Acquisition) 9 of 15
State (North Carolina) 1 of 3
Country (United States) 9 of 15
Year (2012) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-07 Advion BioServices

Ithaca, New York, United States

Advion BioServices, Inc. is a premier U.S.-based bioanalytical laboratory. Company provides Good Laboratory Practice (GLP) pharmacokinetic/pharmacodynamic (PK/PD) testing and other services to biopharma companies worldwide.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-16 Novella Clinical

Morrisville, North Carolina, United States

Novella Clinical, Inc. is a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.

Buy -
Mergr

Product

Company

Legal